The Gastroenterologist's Insider Guide to GLP-1 Agonists: From Semaglutide to Tirzepatide Jan 25, 2025 4 min read As a gastroenterologist, I'm excited to share the latest developments in GLP-1 agonists and their impact on obesity-related gastrointestinal complications
With medications like Wegovy and Saxenda that are specifically approved for weight loss, and others like Ozempic and Trulicity that have shown positive results in managing blood sugar levels and concurrent weight reduction, a robust implementation of GLP-1 drugs could pave the way for a notable reduction in obesity and diabetes-related complications
6 of 7 peptides received positive recommendations DSIP was the only peptide voted NO While these votes are an important step, the FDA still has the final say on Category 1 status
In addition to these physical ailments, some individuals might also consider BPC-157 as part of their New Years resolution, aiming for improved health and wellness overall
Its totally natural to worry about regaining weight when youre thinking about no longer taking Wegovy, semaglutide, or another GLP-1 medication
7% GHK-Cu Accelerant $92.50 HOW TO USE: Based on controlled studies of women in their 50s, active creams containing between 0.03% - 3.0% (a hundredfold difference) produced visible cosmetic effects such as improved appearance and enhanced skin beauty upon self-assessment
